Although many say the drug industry is entering the “post-blockbuster era” as mega-sellers such as Lipitor lose their patents, there are drugs in the pipeline expected to pass the traditional blockbuster benchmark of $1 billion in global annual sales. Here’s a preview of four of them, expected to launch in the next 12 months, that have attracted much interest from Wall Street. Sovaldi: Gilead Sciences’ (GILD) hepatitis C treatment, formerly known
With Twitter now trading and nothing in the immediate tech IPO pipeline that’s nearly as hot, attention shifts to 2014, when some big names are expected to go public. The biggest initial public offering on deck is China e-commerce giant Alibaba Group, with its IPO likely to exceed the Facebook (FB) blockbuster in May 2012 that raised $16 billion. Other big-name techs expected to debut include Square, Dropbox, Box and Pinterest. The Twitter (TWTR)
House Republicans on Tuesday opened the door to rewriting telecom laws for the Internet age, a move cheered by phone and cable TV companies but drawing cautious or no reaction from Democrats, consumer groups and tech companies such as Google. Congress’ last regulatory makeover, the Telecommunications Act of 1996, took several years to pass amid fierce lobbying. But new legislation could address “Net neutrality,” e-commerce sales taxation and other